Back to Trades
Kieffer Tara Lynn
Chief Product Strategy OfficerCIK 0001834835
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Kieffer Tara Lynn, Chief Product Strategy Officer, has filed 4 SEC reports (2025–2026), all concentrated in ENANTA PHARMACEUTICALS INC (ENTA), totaling $1.5M in disclosed volume. Weighing $0 bought versus $30.0K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant | $46.4K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $30.0K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Tax withheld | $10.6K |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Award | $1.4M |
4 filings